Archiv der Pharmazie

Article	Citations
Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors	155
1,2,3‐Triazole hybrids as anticancer agents: A review	108
Coumarin‐containing hybrids and their antibacterial activities	69
Coumarin derivatives with anticancer activities: An update	66
1,2,3‐Triazole hybrids with anti‐HIV‐1 activity	65
Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors	65
Sulfonamides incorporating ketene N,S‐acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors	62
Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3‐diaryltriazene‐substituted sulfathiazole derivatives	59
Determination of the inhibition profiles of pyrazolyl–thiazole derivatives against aldose reductase and α‐glycosidase and molecular docking studies	58
Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds	58
Synthesis, characterization, molecular docking, and biological activities of coumarin–1,2,3‐triazole‐acetamide hybrid derivatives	50
1,3,5‐Triazine: A versatile pharmacophore with diverse biological activities	50
Design and discovery of new 1,2,4‐triazolo[4,3‐c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors	45
Pharmacophore‐linked pyrazolo[3,4‐d]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies	44
Aromatase inhibitors: Role in postmenopausal breast cancer	43
Design, synthesis, and biological activity of novel dithiocarbamate‐methylsulfonyl hybrids as carbonic anhydrase inhibitors	42
Synthesis and antidiabetic evaluation of benzimidazole‐tethered 1,2,3‐triazoles	42
Novel 2‐cyanoacrylamido‐4,5,6,7‐tetrahydrobenzo[b]thiophene derivatives as potent anticancer agents	41
Recent update on antibacterial and antifungal activity of quinoline scaffolds	39
Design, synthesis, molecular docking, and anticancer evaluations of 1‐benzylquinazoline‐2,4(1H,3H)‐dione bearing different moieties as VEGFR‐2 inhibitors	37
Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms	37
Pyrazole–coumarin and pyrazole–quinoline chalcones as potential antitubercular agents	36
Phthalazine‐based VEGFR‐2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations	35
5‐(4‐Methoxybenzylidene)thiazolidine‐2,4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations	33
Natural indole‐containing alkaloids and their antibacterial activities	33

Design, synthesis, molecular modeling, and antimicrobial potential of novel 3‐[(1H‐pyrazol‐3‐yl)imino]indolin‐2‐one derivatives as DNA gyrase inhibitors	33
Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone‐based benzenesulfonamides	32
Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2,4‐dichloro)benzylidene]thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibit	31
Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives	30
In vitro and in silico studies of fluorinated 2,3‐disubstituted thiazolidinone‐pyrazoles as potential α‐amylase inhibitors and antioxidant agents	30
New 1,2,3‐triazole–(thio)barbituric acid hybrids as urease inhibitors: Design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation	29
Pyridine‐derived VEGFR‐2 inhibitors: Rational design, synthesis, anticancer evaluations, in silico ADMET profile, and molecular docking	29
Quinoline‐based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors	28
Ecofriendly synthesis of pyrano[2,3‐d]pyrimidine derivatives and related heterocycles with anti‐inflammatory activities	27
Synthesis of N‐alkylated pyrazolo[3,4‐d]pyrimidine analogs and evaluation of acetylcholinesterase and carbonic anhydrase inhibition properties	27
In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors	27
Oxadiazole: A highly versatile scaffold in drug discovery	26
Synthesis and biological evaluation of some 1‐naphthol derivatives as antioxidants, acetylcholinesterase, and carbonic anhydrase inhibitors	25
Anticancer activity of novel 3‐(furan‐2‐yl)pyrazolyl and 3‐(thiophen‐2‐yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies	25
Novel pyrazole‐clubbed thiophene derivatives via Gewald synthesis as antibacterial and anti‐inflammatory agents	25
Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives	25
Synthesis and in silico studies of triazene‐substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors	25
Azetidines of pharmacological interest	24
N‐Substituted‐4‐phenylphthalazin‐1‐amine‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluation studies	24
Synthesis of benzamide derivatives with thiourea‐substituted benzenesulfonamides as carbonic anhydrase inhibitors	24
Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors	24
Cinnamic acid hybrids as anticancer agents: A mini‐review	23
Indole/isatin‐containing hybrids as potential antibacterial agents	23
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase	23
Novel 1,2,4‐triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies	23
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation	23
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development	22
Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea	22
Recent progress of 1,3,4‐oxadiazoles as anticonvulsants: Future horizons	22
Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease	21
Design and synthesis of pyrazole–pyrazoline hybrids as cancer‐associated selective COX‐2 inhibitors	21
Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds	20
Cytotoxic and antimicrobial potential of benzimidazole derivatives	20
Ginkgo biloba in the management of the COVID‐19 severity	20
Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones	19
Novel benzo[b]xanthene derivatives: Bismuth(III) triflate‐catalyzed one‐pot synthesis, characterization, and acetylcholinesterase, glutathione S‐transferase, and butyrylcholinesterase inhibitor	19
Synthesis, characterization, and biological evaluation of some novel Schiff bases as potential metabolic enzyme inhibitors	19
Biscoumarin–pyrimidine conjugates as potent anticancer agents and binding mechanism of hit candidate with human serum albumin	19
Design, synthesis, and biological evaluation of novel morpholinated isatin–quinoline hybrids as potent anti‐breast cancer agents	19
Synthesis of novel sulfonamides with anti‐Alzheimer and antioxidant capacities	19
(+)‐Camphor and (−)‐borneol derivatives as potential anti‐orthopoxvirus agents	19
Discovery of novel furo[2,3‐d]pyrimidin‐2‐one–1,3,4‐oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis	19
Advances in 2‐substituted benzothiazole scaffold‐based chemotherapeutic agents	18
Design, synthesis, and biological evaluation of isatin‐indole‐3‐carboxaldehyde hybrids as a new class of xanthine oxidase inhibitors	18
Anticancer activity of bisindole alkaloids derived from natural sources and synthetic bisindole hybrids	18
1,2,4‐Triazole hybrids with potential antibacterial activity against methicillin‐resistant Staphylococcus aureus	17
Reprogramming of antibiotics to combat antimicrobial resistance	17
Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX‐2/5‐LOX inhibitors	17
Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety	17
Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021)	17

(E)‐2‐(2‐Allylidenehydrazinyl)thiazole derivatives: Design, green synthesis, in silico and in vitro antimycobacterial and radical scavenging studies	16
Structure–activity relationship studies of indolin‐2‐one derivatives as vascular endothelial growth factor receptor inhibitors and anticancer agents	16
Thieno[2,3‐b]pyridine amines: Synthesis and evaluation of tacrine analogs against biological activities related to Alzheimer's disease	16
Design, synthesis, and biological evaluation of imidazopyridine‐linked thiazolidinone as potential anticancer agents	16
1,2,3‐Triazole‐linked 5‐benzylidene (thio)barbiturates as novel tyrosinase inhibitors and free‐radical scavengers	16
Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR‐γ agonists and thymidylate synthase inhibitors	15
Development of novel indole‐linked pyrazoles as anticonvulsant agents: A molecular hybridization approach	15
In silico molecular docking studies of oxadiazole and pyrimidine bearing heterocyclic compounds as potential antimicrobial agents	15
Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4‐hydroxy‐3,5‐dimethoxy benzaldehyde motif	15
The antimalarial activity of indole alkaloids and hybrids	15
Phyllobilins as a challenging diverse natural product class: Exploration of pharmacological activities	15
Synthesis and anticancer properties of novel hydrazone derivatives incorporating pyridine and isatin moieties	15
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects	15
The anticancer activity of carbazole alkaloids	14
Synthesis, characterization, crystal structure, α‐glycosidase, and acetylcholinesterase inhibitory properties of 1,3‐disubstituted benzimidazolium salts	14
Synthesis and biological evaluation of resveratrol derivatives with anti‐breast cancer activity	14
New N‐phenylacetamide‐linked 1,2,3‐triazole‐tethered coumarin conjugates: Synthesis, bioevaluation, and molecular docking study	14
Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase‐B inhibitors	14
Isatin thiazoles as antidiabetic: Synthesis, in vitro enzyme inhibitory activities, kinetics, and in silico studies	14
Chemical composition and antimicrobial activity of Osage orange (Maclura pomifera) leaf extracts	13
Thiophene‐containing compounds with antimicrobial activity	13
Synthesis and docking calculations of tetrafluoronaphthalene derivatives and their inhibition profiles against some metabolic enzymes	13
New indomethacin analogs as selective COX‐2 inhibitors: Synthesis, COX‐1/2 inhibitory activity, anti‐inflammatory, ulcerogenicity, histopathological, and docking studies	13
Pharmacological report of recently designed multifunctional coumarin and coumarin–heterocycle derivatives	13
PXR–ABC drug transporters/CYP‐mediated ursolic acid transport and metabolism in vitro and vivo	13
Silver–N‐heterocyclic carbene complexes‐catalyzed multicomponent reactions: Synthesis, spectroscopic characterization, density functional theory calculations, and antibacterial study	13
Resveratrol isoforms and conjugates: A review from biosynthesis in plants to elimination from the human body	12
N‐Substituted pyrimidinethione and acetophenone derivatives as a new therapeutic approach in diabetes	12
New quinoxalin‐1,3,4‐oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies	12
A comprehensive review of recent advances in the biological activities of 1,2,4‐oxadiazoles	12
Synthesis and anticancer activity of ethyl 5‐amino‐1‐N‐substituted‐imidazole‐4‐carboxylate building blocks	12
Synthesis, anti‐inflammatory activity, and molecular docking studies of some novel Mannich bases of the 1,3,4‐oxadiazole‐2(3H)‐thione scaffold	12
Exploration of thiazolidine‐2,4‐diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations	12
Investigation of HMG‐CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives	12
Effect of substituents in the A and B rings of chalcones on antiparasite activity	12
Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine‐1,1‐dioxide derivatives	11
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models	11
Synthesis and antimicrobial evaluation of new nitric oxide‐donating fluoroquinolone/oxime hybrids	11
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes	11
Catechol‐bearing imidazolium and benzimidazolium chlorides as promising antimicrobial agents	11
Novel N‐benzylpiperidine derivatives of 5‐arylisoxazole‐3‐carboxamides as anti‐Alzheimer's agents	11
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers	11
Design, synthesis, and molecular docking study of new monastrol analogues as kinesin spindle protein inhibitors	11
The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers	11
Some phenolic natural compounds as carbonic anhydrase inhibitors: An in vitro and in silico study	11
Synthesis and antimalarial and anticancer evaluation of 7‐chlorquinoline‐4‐thiazoleacetic derivatives containing aryl hydrazide moieties	11
Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation	11
Novel benzenesulfonamide‐bearing pyrazoles and 1,2,4‐thiadiazoles as selective carbonic anhydrase inhibitors	11
Design, synthesis, and cytotoxicity screening of new synthesized imidazolidine‐2‐thiones as VEGFR‐2 enzyme inhibitors	10
Discovery of 2,4‐diaminopyrimidine derivatives targeting p21‐activated kinase 4: Biological evaluation and docking studies	10
Facile synthesis of C6‐substituted benz[4,5]imidazo[1,2‐a]quinoxaline derivatives and their anticancer evaluation	10
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors	10
3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4,5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde dehydrogenase 1A1 inhibito	10
Synthesis and evaluation of novel xanthene‐based thiazoles as potential antidiabetic agents	10
Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives	10
Design, synthesis, and α‐glucosidase‐inhibitory activity of phenoxy‐biscoumarin–N‐phenylacetamide hybrids	10
Synthesis and biological evaluation of new coumarin derivatives as cytotoxic agents	10
Potential targeting of Hep3B liver cancer cells by lupeol isolated from Avicennia marina	9
Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease	9
Novel promising benzoxazole/benzothiazole‐derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis	9
Evaluation of isoindole derivatives: Antioxidant potential and cytotoxicity in the HT‐29 colon cancer cells	9
Simultaneous analysis of oxytetracycline hydrochloride, lidocaine, and bromhexine hydrochloride in the presence of many interfering excipients	9
In silico studies, nitric oxide, and cholinesterases inhibition activities of pyrazole and pyrazoline analogs of diarylpentanoids	9
Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR‐2 inhibitors	9
3′‐Methyl‐4‐thio‐1H‐tetrahydropyranspiro‐5′‐hydantoin platinum complex as a novel potent anticancer agent and xanthine oxidase inhibitor	9
Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies	9
Cyanopropyl functionalized benzimidazolium salts and their silver N‐heterocyclic carbene complexes: Synthesis, antimicrobial activity, and theoretical analysis	9
Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin–1,2,4‐triazole scaffolds	9
Synthesis and biological evaluation of substituted pyrrolidines and pyrroles as potential anticancer agents	9
Probing simple structural modification of α‐mangostin on its cholinesterase inhibition and cytotoxicity	9
Comparison of extraction efficiency and selectivity between low‐temperature pressurized microwave‐assisted extraction and prolonged maceration	9
Synthesis and radioligand‐binding assay of 2,5‐disubstituted thiadiazoles and evaluation of their anticonvulsant activities	9
Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies	9
Binding of boswellic acids to functional proteins of the SARS‐CoV‐2 virus: Bioinformatic studies	8
Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX‐2 inhibitors	8
Systematic response of staurosporine scaffold‐based inhibitors to drug‐resistant cancer kinase mutations	8
Design, synthesis, and molecular docking study of novel quinoline‐based bis‐chalcones as potential antitumor agents	8
Antiprotozoal agents: How have they changed over a decade?	8
Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors	8
Synthesis and biological evaluation of Val–Val dipeptide–sulfonamide conjugates	8

Synthesis of novel 4,5‐dihydropyrrolo[1,2‐a]quinoxalines, pyrrolo[1,2‐a]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity	8
Synthesis, structural characterization, and biological studies of ATBS–M complexes (M(II) = Cu, Co, Ni, and Mn): Access for promising antibiotics and anticancer agents	8
Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment	8
Current perspectives on naturally occurring saponins as anticancer agents	8
Bioevaluation of synthetic pyridones as dual inhibitors of α‐amylase and α‐glucosidase enzymes and potential antioxidants	8
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19	8
Molecular hydrogen (H2) as a potential treatment for acute and chronic fatigue	8
Upregulation of BAX and caspase‐3, as well as downregulation of Bcl‐2 during treatment with indeno[1,2‐b]quinoxalin derivatives, mediated apoptosis in human cancer cells	8
Synthesis, cytotoxicity, and molecular docking of substituted 3‐(2‐methylbenzofuran‐3‐yl)‐5‐(phenoxymethyl)‐1,2,4‐oxadiazoles	8
Synthesis and biological evaluation of novel isoxazole derivatives from acridone	8
A new series of hydrazones as small‐molecule aldose reductase inhibitors	8
Antitumor and multikinase inhibition activities of some synthesized coumarin and benzofuran derivatives	8
Design and synthesis of new lenalidomide analogs via Suzuki cross‐coupling reaction	8
Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3‐c]quinazolines as classical DNA intercalators	8
1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities	7
Bioevaluation of quinoline‐4‐carbonyl derivatives of piperazinyl‐benzothiazinones as promising antimycobacterial agents	7
Eugenol carbonate activity against Plasmodium falciparum, Leishmania braziliensis, and Trypanosoma cruzi	7
Hybridization‐based design of novel anticholinesterase indanone–carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies	7
Design and synthesis of benzenesulfonamide‐linked imidazo[2,1‐b][1,3,4]thiadiazole derivatives as carbonic anhydrase I and II inhibitors	7
Design, synthesis, and antiproliferative effect of 2,9‐bis[4‐(pyridinylalkylaminomethyl)phenyl]‐1,10‐phenanthroline derivatives on human leukemic cells by targeting G‐quadruplex	7
Drug re‐engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery	7
Development of new Alzheimer's disease drug candidates using donepezil as a key model	7
Synthesis, docking studies, and pharmacological evaluation of 2‐hydroxypropyl‐4‐arylpiperazine derivatives as serotoninergic ligands	7
Zinc(II) complexation strategy for ultra‐sensitive fluorimetric estimation of molnupiravir: Applications and greenness evaluation	7
Design, synthesis, biological evaluation, and in silico studies of 2‐aminobenzothiazole derivatives as potent PI3Kα inhibitors	7
Recent advances in indole dimers and hybrids with antibacterial activity against methicillin‐resistant Staphylococcus aureus	7
The antimalarial activity of 1,2,4‐trioxolane/trioxane hybrids and dimers: A review	7
Piperazine and piperidine‐substituted 7‐hydroxy coumarins for the development of anti‐inflammatory agents	7
Synthesis of new 1,2,4‐triazole–(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis	7
Synthesis and biological evaluation of coumarin‐thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors	7
Synthesis and antitumor potential of new arylidene ursolic acid derivatives via caspase‐8 activation	7
Design, synthesis, evaluation, and molecular modeling studies of indolyl oxoacetamides as potential pancreatic lipase inhibitors	7
Design, synthesis, and in silico studies of tetrahydropyrimidine analogs as urease enzyme inhibitors	7
New nanodrug design for cancer therapy: Its synthesis, formulation, in vitro and in silico evaluations	7
Green synthesis of pregabalin‐stabilized gold nanoclusters and their applications in sensing and drug release	7
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands	7
A new series of benzoxazole‐based SIRT1 modulators for targeted therapy of non‐small‐cell lung cancer	7
New halogenated chalcones with cytotoxic and carbonic anhydrase inhibitory properties: 6‐(3‐Halogenated phenyl‐2‐propen‐1‐oyl)‐2(3H)‐benzoxazolones	7
Synthesis and antimicrobial activity of new 2‐piperazin‐1‐yl‐N‐1,3‐thiazol‐2‐ylacetamides of cyclopenta[c]pyridines and pyrano[3,4‐c]pyridines	7
Novel 2‐substituted thioquinazoline‐benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity	7
Insights into the chemistry and therapeutic potential of acrylonitrile derivatives	7
Influence of the pKa value on the antioxidant activity of licorice flavonoids under solvent‐mediated effects	7
Triazoloquinazoline derived classical DNA intercalators: Design, synthesis, in silico ADME profile, docking, and antiproliferative evaluations	7
Synthesis of new arylazopyrazoles as apoptosis inducers: Candidates to inhibit proliferation of MCF‐7 cells	7
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors	7
Synthesis of new 7‐amino‐3,4‐dihydroquinolin‐2(1H)‐one‐peptide derivatives and their carbonic anhydrase enzyme inhibition, antioxidant, and cytotoxic activities	7
Antiproliferative effects of chalcones on T cell acute lymphoblastic leukemia‐derived cells: Role of PKCβ	7